Simeprevir and sofosbuvir with modified doses of ribavirin (RBV) therapy on telaprevir experienced co infected (with HIV) cirrhotics with chronic hepatitis C (CHC). A randomized open label clinical pilot study: Stop C

Authors
Category Primary study
JournalJournal of Hepatology
Year 2015
This article has no abstract
Epistemonikos ID: d18024f849bd3afd6123ab163d6e75fb8d996e4d
First added on: Feb 07, 2025